In January 1996, the investment manager of hedge fund is considering buying a stake in the start-up biotechnology company, Rocky Mountain Advanced Genome (RMAG). The asking price is $ 46 million for a 90% stake. Although the leaders of the company are optimistic about their future activities, the investment manager is more conservative in their expectations. She asks analyst fashion counterproposal to control RMAG in. Problems for students to apply the concept of the ultimate cost, completed tests and interpret data, and to receive the consequences of various terminal value assumptions to recommend a counteroffer. Small computing requires students.
This Darden study. "Hide
by Robert F. Bruner Source: Darden School of Business 20 pages. Publication Date: April 3, 1996. Prod. #: UV0005-PDF-ENG
Related Case Solutions & Analyses:
The Commerce Tavern
Marcia Radosevich and Health Payment Review–1989 (C)
American Express Travel Related Services Co.
Precision Parts Inc. (A)
General Electric–Thermocouple Manufacturing (B)
Advance Technologies
The Bayan Tree
Are Voting Guidelines Ruling Your Business?
Billy Beane and the Oakland Athletics (A): Disruptive Innovation in Major League Baseball
China: Facing the 21st Century
